Patents by Inventor Jane McKeating

Jane McKeating has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230000917
    Abstract: The present invention provides an acyl-CoA: cholesterol acyltransferase (ACAT) inhibitor for use in the treatment of hepatitis B vims (HBV) infection in a subject.
    Type: Application
    Filed: November 27, 2020
    Publication date: January 5, 2023
    Inventors: Mala Maini, Nathalie Schmidt, Alice Burton, Jane Mckeating, Peter Wing
  • Publication number: 20060069027
    Abstract: The present invention relates to methods that employ peptides or peptide derivatives to inhibit hepatitis C virus infection. The present invention is based in part on the discovery that E2 envelope glycoprotein of hepatitis C virus has previously undescribed domains that are important for interactions with cellular or viral proteins that are necessary for early steps in HCV infection. The present invention provides peptides and methods of treatment and prophylaxis of diseases induced by hepatitis C virus and related viruses.
    Type: Application
    Filed: September 26, 2005
    Publication date: March 30, 2006
    Inventors: Robert Garry, Jane McKeating